[go: up one dir, main page]

FI102074B1 - Förfarande för framställning av en antagonistdekapeptid till en luteinseringshormon frigörande hormon - Google Patents

Förfarande för framställning av en antagonistdekapeptid till en luteinseringshormon frigörande hormon

Info

Publication number
FI102074B1
FI102074B1 FI900947A FI900947A FI102074B1 FI 102074 B1 FI102074 B1 FI 102074B1 FI 900947 A FI900947 A FI 900947A FI 900947 A FI900947 A FI 900947A FI 102074 B1 FI102074 B1 FI 102074B1
Authority
FI
Finland
Prior art keywords
antide
decapeptide
hormone
niclys
pclphe
Prior art date
Application number
FI900947A
Other languages
English (en)
Finnish (fi)
Other versions
FI900947A0 (fi
FI102074B (sv
Inventor
Karl Folkers
Cyril Y Bowers
Anders Ljungquist
Pui-Fun Louisa Tang
Minoru Kobota
Dong-Mei Feng
Original Assignee
Univ Texas
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Univ Tulane filed Critical Univ Texas
Publication of FI900947A0 publication Critical patent/FI900947A0/fi
Application granted granted Critical
Publication of FI102074B1 publication Critical patent/FI102074B1/sv
Publication of FI102074B publication Critical patent/FI102074B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
FI900947A 1987-08-24 1990-02-23 Förfarande för framställning av en antagonistdekapeptid till en lutein seringshormon frigörande hormon FI102074B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/088,431 US4935491A (en) 1987-08-24 1987-08-24 Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US8843187 1987-08-24
US8802922 1988-08-24
PCT/US1988/002922 WO1989001944A1 (en) 1987-08-24 1988-08-24 Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine

Publications (3)

Publication Number Publication Date
FI900947A0 FI900947A0 (fi) 1990-02-23
FI102074B1 true FI102074B1 (sv) 1998-10-15
FI102074B FI102074B (sv) 1998-10-15

Family

ID=22211329

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900947A FI102074B (sv) 1987-08-24 1990-02-23 Förfarande för framställning av en antagonistdekapeptid till en lutein seringshormon frigörande hormon

Country Status (14)

Country Link
US (3) US4935491A (sv)
EP (1) EP0377665B1 (sv)
JP (1) JP2621970B2 (sv)
KR (1) KR0135276B1 (sv)
AT (1) ATE124957T1 (sv)
AU (1) AU619221B2 (sv)
DE (1) DE3854159T2 (sv)
DK (1) DK173753B1 (sv)
FI (1) FI102074B (sv)
HU (2) HU213098B (sv)
MX (1) MX9203688A (sv)
NO (1) NO301015B1 (sv)
OA (1) OA09786A (sv)
WO (1) WO1989001944A1 (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
US5352796A (en) * 1989-10-30 1994-10-04 The Salk Institute For Biological Studies Amino acids useful in making GnRH analogs
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
US5212288A (en) * 1990-02-20 1993-05-18 Syntex (U.S.A.) Inc. Temporary minimal protection synthesis of serine-containing polypeptides
US5180711A (en) * 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5169935A (en) * 1990-06-20 1992-12-08 The Salk Institute For Biological Studies Method of making peptides
US5744450A (en) * 1991-03-14 1998-04-28 The Salk Institute For Biological Studies GnRH analogs
CA2108977C (en) * 1991-04-25 2002-12-17 Romano Deghenghi Luteinizing hormone releasing hormone antagonist peptides
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
US5656727A (en) * 1992-09-15 1997-08-12 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
RU2130464C1 (ru) * 1993-05-20 1999-05-20 Биотек Аустралиа Пти, Лимитед Антагонист лг-рилизинг-фактора (lhrh), комплекс, способ химической кастрации и/или лечения гонадотропинзависимых расстройств
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US6566330B1 (en) 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
EP0880969A1 (en) * 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Pharmaceutical compositions of peptides having low solubility in physiological medium
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
WO1999055376A1 (en) 1998-04-28 1999-11-04 Applied Research Systems Ars Holding N.V. Peg-lhrh analog conjugates
US7953788B2 (en) 2001-09-29 2011-05-31 Siebel Systems, Inc. System and method for queuing data for an application server
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
US7109171B2 (en) * 2000-02-28 2006-09-19 Praecis Pharmaceuticals Inc. Methods for treating FSH related conditions with GnRH antagonists
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
JP4748923B2 (ja) * 2000-12-27 2011-08-17 アレス トレーディング ソシエテ アノニム 低温微粉砕による脂質マイクロ粒子
JP2002201168A (ja) * 2000-12-28 2002-07-16 Kaken Pharmaceut Co Ltd シクロヘキサン誘導体
AU2002235348A1 (en) * 2001-01-17 2002-07-30 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
FR2840532B1 (fr) * 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
EP1711159B1 (en) 2003-12-30 2013-03-20 Durect Corporation Solid implants containing a block copolymer for controlled release of a gnrh compound
JP4927729B2 (ja) * 2004-07-16 2012-05-09 オークウッド ラボラトリーズ，エル．エル．シー． 性腺刺激ホルモン放出ホルモンアンタゴニスト
WO2006080256A1 (ja) * 2005-01-26 2006-08-03 Sumitomo Seika Chemicals Co., Ltd. １－（６－メチルピリジン－３－イル）－２－［４－（メチルスルホニル）フェニル］エタノンの製造方法および製造中間体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
AU9102582A (en) * 1981-12-10 1983-06-16 David Howard Coy Lh-rh antagonists
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4504414A (en) * 1983-03-28 1985-03-12 Board Of Regents, The University Of Texas System Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
US4530920A (en) * 1983-11-07 1985-07-23 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4652550A (en) * 1984-05-21 1987-03-24 The Salk Institute For Biological Studies GnRH antagonists VII
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
US4647653A (en) * 1984-08-23 1987-03-03 Tulane Educational Fund Therapeutic peptides
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
EP0199302A2 (en) * 1985-04-19 1986-10-29 Syntex (U.S.A.) Inc. Contraception in dogs with luteinizing hormone releasing hormone antagonists
EP0225746A3 (en) * 1985-11-14 1989-12-20 The Administrators of The Tulane Educational Fund Therapeutic decapeptides
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
ES2108684T3 (es) * 1988-02-10 1998-01-01 Tap Pharmaceuticals Inc Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).
US5180711A (en) * 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH

Also Published As

Publication number Publication date
HUT59940A (en) 1992-07-28
US5470947A (en) 1995-11-28
DE3854159T2 (de) 1996-02-15
OA09786A (en) 1994-04-15
HU211882A9 (en) 1995-12-28
HU213098B (en) 1997-02-28
FI900947A0 (fi) 1990-02-23
EP0377665B1 (en) 1995-07-12
NO301015B1 (no) 1997-09-01
MX9203688A (es) 1992-09-01
DE3854159D1 (de) 1995-08-17
FI102074B (sv) 1998-10-15
JP2621970B2 (ja) 1997-06-18
US4935491A (en) 1990-06-19
US5763404A (en) 1998-06-09
DK48690D0 (da) 1990-02-23
KR0135276B1 (ko) 1998-04-23
NO900888L (no) 1990-04-23
NO900888D0 (no) 1990-02-23
WO1989001944A1 (en) 1989-03-09
HU885868D0 (en) 1991-12-30
JPH03501969A (ja) 1991-05-09
DK173753B1 (da) 2001-09-10
ATE124957T1 (de) 1995-07-15
DK48690A (da) 1990-04-19
AU619221B2 (en) 1992-01-23
KR890701117A (ko) 1989-12-19
EP0377665A1 (en) 1990-07-18
AU2529488A (en) 1989-03-31

Similar Documents

Publication Publication Date Title
FI102074B1 (sv) Förfarande för framställning av en antagonistdekapeptid till en luteinseringshormon frigörande hormon
Vickery Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists
AU746132B2 (en) LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
CA1339043C (en) Nonapeptide and decapetide analogs of lhrh useful as lhrh antagonists
SE8007763L (sv) Sett att framstella en polypeptid
Ljungqvist et al. Antide and related antagonists of luteinizing hormone release with long action and oral activity.
DK395688A (da) Lhrh-antagonister, deres fremstilling og laegemidler der indeholder dem
HRP980197A2 (en) GnRH ANTAGONISTS
Coy et al. Gonadotrophin releasing hormone analogues
Sandow et al. Structure-activity relationships in the LH-RH molecule
PH18965A (en) Gnrh antagonists,pharmaceutical compositions containing the same and method of use thereof
ES8207511A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
Sharma et al. The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate
Kovacs et al. Long-term inhibition of ovulation by a GnRH-antagonist at low dose level
Pinski et al. Recovery of pituitary‐gonadal function in male rats after long‐term suppression induced by a single injection of microcapsules of LH‐RH antagonist Cetrorelix (SB‐75)
Pinski et al. Comparison of biological effects of a sustained delivery system and nonencapsulated LH-RH antagonist SB-75 in rats
ATE59393T1 (de) Peptide.
Pinski et al. Evaluation of biological activities of new LH‐RH antagonists (T‐series) in male and female rats
Crighton The effects of synthetic gonadotrophin releasing factor on the release of luteinizing hormone and follicle-stimulating hormone from ovine pituitary tissue in vitro
Coy et al. Structure—Function of LH-RH Analogs and Design Applications to other Peptide Systems
Gardner et al. The use of GnRH agonists
Casper successive doses of GnRH agonists throughout the human menstrual cycle

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE ADMINISTRATORS OF THE TULANE

Owner name: BOARD OF REGENTS, THE UNIVERSITY OF

MA Patent expired